Veronica Byfield Sköld
Director Ejecutivo en BioLamina AB .
Cargos activos de Veronica Byfield Sköld
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Director Ejecutivo | 01/10/2021 | - |
| Director/Miembro de la Junta | 01/04/2021 | - |
Historial de carrera de Veronica Byfield Sköld
Antiguos cargos conocidos de Veronica Byfield Sköld.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CLEMONDO GROUP AB | Ventas & Marketing | 01/08/2020 | - |
Formación de Veronica Byfield Sköld.
| Royal Institute of Technology | Graduate Degree |
| IHM Business School AB | Undergraduate Degree |
Estadísticas
Internacional
| Suecia | 5 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLEMONDO GROUP AB | Consumer Non-Durables |
| Empresas privadas | 1 |
|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
